India point of care diagnostics market size is projected to exhibit a growth rate (CAGR) of 9.20% during 2024-2032. The increasing incidence of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases, coupled with the rising demand for rapid and efficient diagnostic solutions at the point of care, is driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023 |
Forecast Years
|
2024-2032 |
Historical Years
|
2018-2023
|
Market Growth Rate (2024-2032) | 9.20% |
Point of care diagnostics (POCD) refers to medical tests performed near the patient, typically outside of traditional laboratory settings. These tests provide rapid results, enabling quick decision-making by healthcare professionals. The primary goal is to deliver timely and accurate diagnostic information to improve patient outcomes. POCD is particularly valuable in emergency situations, remote or resource-limited settings, and for monitoring chronic conditions. Key advantages include reduced turnaround time, minimized transportation delays, and increased accessibility, especially in regions with limited infrastructure. POCD technologies encompass a wide range of methods, including rapid tests, portable devices, and mobile health applications. Overall, POCD contributes to more efficient healthcare delivery, personalized treatment plans, and enhanced disease management, ultimately leading to better patient care and outcomes.
The point -of-care diagnostics market in India is experiencing significant growth, driven by several key factors. Firstly, the rising prevalence of infectious diseases regionally has fueled the demand for rapid and on-the-spot diagnostic solutions. Additionally, the increasing focus on personalized medicine and the need for immediate results to inform timely treatment decisions have propelled the POCD market forward. Furthermore, advancements in technology, particularly in the fields of biosensors and mobile health applications, have enabled the development of innovative and user-friendly point of care devices, enhancing accessibility and convenience. Moreover, the growing awareness among healthcare professionals and patients regarding the benefits of early diagnosis and the potential for improved patient outcomes has spurred the adoption of POCD. The trend toward decentralization of healthcare services, with a shift from traditional laboratory settings to point of care settings, is another driving force behind the market's expansion. Furthermore, regulatory initiatives supporting the development and commercialization of POCD devices have provided a conducive environment for market growth. In conclusion, a confluence of factors, including disease prevalence, technological advancements, awareness, and regulatory support, is propelling the regional market on a trajectory of sustained growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product type, platform, prescription mode, and end user.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes blood-glucose monitoring kit, cardio-metabolic monitoring kit, pregnancy and fertility testing kit, infectious disease testing kit, cholesterol test strip, hematology testing kit, and others.
Platform Insights:
A detailed breakup and analysis of the market based on the platform have also been provided in the report. This includes lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays.
Prescription Mode Insights:
The report has provided a detailed breakup and analysis of the market based on the prescription mode. This includes prescription-based testing and OTC testing.
End User Insights:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes professional diagnostic centers, home care, research laboratories, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, West and Central India, South India, and East and Northeast India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Blood-Glucose Monitoring Kit, Cardio-Metabolic Monitoring Kit, Pregnancy and Fertility Testing Kit, Infectious Disease Testing Kit, Cholesterol Test Strip, Hematology Testing Kit, Others |
Platforms Covered | Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays |
Prescription Modes Covered | Prescription-based Testing, OTC Testing |
End Users Covered | Professional Diagnostic Centers, Home Care, Research Laboratories, Others |
Regions Covered | North India, West and Central India, South India, East and Northeast India |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 2699 Five User License: US$ 3699 Corporate License: US$ 4699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |